APA (7th ed.) Citation

M, B., S, Z., MC, A., T, A., ML, B., DW, B., . . . D, E. (2025). Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains. Current rheumatology reports, 27(1), 41. https://doi.org/10.1007/s11926-025-01202-y

Chicago Style (17th ed.) Citation

M, Barbhaiya, et al. "Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains." Current Rheumatology Reports 27, no. 1 (2025): 41. https://doi.org/10.1007/s11926-025-01202-y.

MLA (9th ed.) Citation

M, Barbhaiya, et al. "Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains." Current Rheumatology Reports, vol. 27, no. 1, 2025, p. 41, https://doi.org/10.1007/s11926-025-01202-y.